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a  b  s  t  r  a  c  t
The  most  basic  stochastic  epidemic  models  are  those  involving  global  transmission,  meaning  that  infec-
tion  rates  depend  only  on  the  type and state  of  the  individuals  involved,  and  not  on their location  in  the
population.  Simple  as  they  are,  there  are  still  several  open  problems  for such  models.  For  example,  when
will such  an  epidemic  go  extinct  and  with what  probability  (questions  depending  on  the  population  being
ﬁxed,  changing  or growing)?  How  can a  model  be  deﬁned  explaining  the  sometimes  observed  scenarioeywords:
tochastic epidemics
lobal transmission
xtinction
enetic evolution
of  frequent  mid-sized  epidemic  outbreaks?  How  can  evolution  of  the  infectious  agent transmission  rates
be  modelled  and  ﬁtted  to  data  in  a  robust  way?
©  2014  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).ndemicity
. Introduction and classiﬁcation
Epidemic processes are essentially stochastic, but stochastic
pidemic models have not had a straightforward history. That
pidemics proceed by chance contacts with individuals was under-
tood from the earliest days of modelling, but early modelling
evelopments were deterministic. The development of stochas-
ic models, from the 1950s onward (e.g. Bailey, 1950; Bartlett,
956), was in parallel with developments in techniques, starting
ith models that dealt in total numbers of infecteds, suscepti-
les, etc. Individual-based models came in ﬁrst to deal with spatial
opulations (1970s), with subsequent developments related to
omputer methodology (simulations, inference) and network the-
ry.Stochastic models can conveniently be classiﬁed according to
hether their contact structure is global, network, metapopulation
r spatial. Given the many other aspects of disease to be modelled,
∗ Corresponding author. Tel.: +46 8164534.
E-mail address: tom.britton@math.su.se (T. Britton).
ttp://dx.doi.org/10.1016/j.epidem.2014.05.002
755-4365/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unthere is good reason to model contact structure as simply as possi-
ble. Models with too many parameters cannot usefully be ﬁtted: as
Euler is reputed to have said, ‘Give me  four parameters and I will
draw you an elephant, ﬁve and I will have him wave his trunk’.
The simplest contact structure is no structure, often referred to
as either global or homogeneous mixing (Mollison, 1995). Individ-
uals’ probabilities of interaction do not depend on their location
in the population, such as their social group or spatial location.
Global models can incorporate individual heterogeneity, for exam-
ple by having different rates of infection for individuals of different
age, sex, or infection history. Numerous examples of (determinis-
tic) global models, over the range of diseases important to humans,
can be found in Anderson and May  (1992).
Network epidemic models (Pellis et al., in this volume) are more
difﬁcult to deﬁne. Any individual-based epidemic model can be
thought of as a network or random graph: with individuals as nodes,
and infection of one by another as a link. The question is rather
whether network theory can be usefully applied. In recent years
network models have been notably successful in analysing mod-
els where individuals vary greatly in their number of contacts (the
degree distribution of the underlying graph).
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Metapopulation models (Ball et al., in this volume) deal with
ases where interactions do depend on social group. The basic case
s where the population is partitioned into non-overlapping groups,
.g. households; individuals have one contact rate with individuals
n different groups, and another (higher) rate for individuals in the
ame group. More general metapopulation models allow an indi-
idual to belong to several different types of group, each with its
wn contact rate, or allow more levels of mixing.
Spatial models (Riley et al., in this volume) vary from sim-
le lattices with only nearest–neighbour interactions, for which
ome theoretical analysis is possible, to complex models with long-
istance interactions, for which only qualitative and approximate
esults are known. A key feature of spatial models is that they dis-
lay slower than exponential growth, even in their earliest stage;
his makes it difﬁcult to approximate them adequately by deter-
inistic models, and even to deﬁne threshold parameters.
As a simple example to illustrate these different types of model,
onsider a disease among two type of individual, male and female.
n each case consider a simple Markov process SIR, in which infected
ndividuals (I) have an exponentially distributed infectious period
efore being removed (R), during which they may  infect suscepti-
les (S) as follows. First, suppose that the infection rates between
ny (I,S) pair depends only on the types of the individuals involved
perhaps individuals can only infect others of the opposite sex, and
erhaps the rates from male to female and female to male are dif-
erent); this is a global model. Second, suppose the individuals live
istributed between a number of different villages, and that the
ates of infection have two levels, with higher infection rates if the
I,S) pair live in the same village, lower if they live in different vil-
ages; this is a metapopulation model. Third, suppose instead that
he individuals live in a line of houses equally spaced along a street,
nd that the infection rate between I and S depends on the distance
etween the houses they live in (normally one would take this to
e a decreasing function of distance); this is a spatial model. Finally,
n any of these populations, suppose that we think of individuals as
ertices of a graph, with edges of the graph connecting pairs that
ave some kind of social relationship; and then take rates of infec-
ion between connected individuals that only depend on their type;
his is a network model. Note that all the other three examples can
e considered as network models, if we draw edges between all
airs of individuals (everyone knows everyone”), and add depend-
nce of infection rates on village or distance as appropriate.
We  are now ready to state our ﬁrst challenge, namely: is this
lassiﬁcation into global, network, metapopulation and spatial
odels sufﬁcient for the range of contact structures of interest in
nderstanding infectious disease dynamics?
The focus of the present paper is global stochastic epidemic
odels, where any (infectious) individual may  infect any other
susceptible) individual at a transmission rate that may  differ
etween different pairs of individuals, but should be of the same
rder 1/N (or 0), where N is the population size. The simplest model
ssumption is where all transmission rates are identical, which is
alled a homogeneously mixing population of homogeneous indi-
iduals, but one may  also assume different mixing rates and/or
hat individuals are of different types with respect to susceptibility
nd/or infectivity. As we shall see in this section, there are sev-
ral open problems also for global epidemic models (only having
ransmission on a global scale). In real world epidemics there is of
ourse nearly always some local structure within which transmis-
ion is much higher. Still, results for global epidemic models have
ndoubtedly been most inﬂuential in affecting health policies, and
or highly transmittable diseases global mixing is often a reasonable
pproximation.
Having speciﬁed identical transmission rates (between all pairs
f individuals) does not deﬁne the model uniquely. Other aspects
o consider in formulating a stochastic model include.s 10 (2015) 54–57 55
Type of epidemic model. An SI model is where Susceptibles may
become infected and infectious, and if they do, they remain infec-
tious forever. In an SIR model, individuals that are infectious (from
now on denoted Infectives) eventually recover from the disease and
become immune for the rest of their lives (measles and chicken-pox
being two examples). An SIS model is where infectives, rather than
recovering and becoming immune they recover and enter the sus-
ceptible state again. SEIS models admit that there is a latent (E for
exposed) state where an individual has already been infected but
where he or she has not yet started to shed virus or bacteria. Other
examples, hopefully self-explanatory, are SEIR, SIRS, SEIRS, . . .
Treatment of time. Is the time evolution of the epidemic of
interest or only the end/ﬁnal state of an outbreak? Is discrete or
continuous time more appropriate? Do all rates/probabilities obey
the practical Markov property (that future events only depend on
present states and not the history, meaning that all underlying dis-
tributions are exponentials), or are durations not all exponentially
distributed?
Population. Are we  considering a ﬁxed and ﬁnite population of
size N, or a population having births and deaths but ﬂuctuating ran-
domly around N, or even a growing population? If the time-frame
of interest is short, then a ﬁxed population model might sufﬁce,
whereas if interest is on longer periods, a dynamic population is
more realistic, thus allowing for inﬂux of new individuals. If the
population size ﬂuctuates randomly around N it will eventually die
out with probability 1 (and the disease will go extinct before this
happens) so questions of interest then relate to population-disease
properties prior to extinction (quasi-endemic) and the length of
time to extinction of the disease. Alternatively, if the population
grows, then it may  happen that the disease will remain present in
the population for ever (endemic situation).
Fluctuations over time. Do all event rates stay the same over time
except for the numbers “at risk”? The simplest models answer this
question with a yes, but there are situations where this is clearly
not the case, for example when the infectious agent evolves on the
same time scale as the epidemic outbreak, and/or because individ-
uals start taking precautions as more and more people are struck
by the disease. A (perhaps simpler) ﬂuctuation over time is where
individuals and/or transmission rates change over time for reasons
other than the epidemic itself. Examples include seasonality due to
school term and school closure, but also varying transmission rates
due to changes in temperature.
These type of questions are dealt with in the remainder of the
current paper, and several challenges for these type of models are
listed.
2. Endemicity: persistence of infection
Bartlett’s seminal paper (Bartlett, 1956) highlighted a severe
inadequacy of deterministic models in describing the persistence
of infection in an SIR (or similar) process with demography: ﬂuc-
tuations in the prevalence of infection about the endemic level can
often be large enough for transmission to be interrupted by stochas-
tic fade-out. Using a stochastic linearization approach, Bartlett
estimated the magnitude of these ﬂuctuations and characterizing
the critical community size required for the persistence of such
infections (most notably, for measles). This approach, later formal-
ized in terms of an Ornstein–Uhlenbeck process, provides the basis
of later work that derives approximations for the time to extinction
when starting at the endemic (quasi-)equilibrium (e.g. Nåsell, 1999,
and others). Improved approximations can be obtained using large
deviation theory (e.g. Kamenev and Meerson, 2008).
The question of endemic persistence is most pointed for a
newly-introduced infection given that the initial epidemic is the
most severe. While it is well known how to compute the probability
5 idemic
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hat an epidemic takes off when N is large (e.g. Ball, 1983), a
ore challenging question is how to calculate the probability that
he infection persists through the trough that follows the initial
pidemic. In particular, how does this probability depend on the
arameters of the infection process (i.e. the transmission param-
ter and recovery rate), the birth rate and the population size?
an Herwaarden (1997) provides an approximate answer, obtained
y asymptotic solution of a boundary value problem applied to a
okker–Planck equation, and more recently, Meerson and Sasorov
2009) have used large deviation theory and the WKB  (Wentzel-
ramers-Brillouin) approximation approach to attack the problem.
Challenges remain in extending this work beyond the simplest
ettings, for instance when there is extrinsic seasonal variation in
ransmission (e.g. the seasonally forced outbreaks of measles in the
re-vaccine era) or for infections with more complex lifecycles (e.g.
ector-borne infections).
. Near-critical behaviour
Many disease systems of interest are neither strongly super-
ritical (with large outbreaks possible), nor subcritical (with large
utbreaks impossible), but instead exhibit ‘stuttering’ behaviour of
epeated, mid-sized outbreaks. This is particularly true for emerg-
ng zoonotic infections (Lloyd-Smith et al., 2009) and diseases
here transmission has been signiﬁcantly reduced due to eradi-
ation or elimination efforts (Klepac et al., 2013). Blumberg and
loyd-Smith (2013) review approaches to this problem based on
stimation of the parameters of a sub-critical branching process,
owever this problem is inherently extremely hard and has already
een identiﬁed by Lloyd-Smith et al. (2009) as an issue requiring
dditional attention from modellers. In particular, the clustering
f unvaccinated individuals (see also the paper ‘Network Mod-
ls’ in this journal issue) means that the homogeneous mixing
ssumption underlying commonly used branching process meth-
ds may  be inappropriate. Even once an appropriate model has
een selected, data that are available are likely to be at best weakly
nformative about the value of R0.
A signiﬁcant challenge is therefore to obtain a thorough under-
tanding of the information content of near-critical branching
rocesses, together with methods for data collection and quantiﬁ-
ation of relevant uncertainties is a key challenge for understanding
iseases that are emerging, or close to elimination.
. Epidemics in growing populations
Rigorous analysis of stochastic SIR epidemics is mainly focussed
n static populations, which do not allow for demographic turnover
hrough births and deaths. There is need for models for such
pidemics in populations which have demographic turnover and
o further extensions to populations with some social structure
escribed through households or a network model.
If a population with demographic turnover has a large (quasi)
tationary state, then an SIR epidemic will go extinct if there is no
mportation of the disease from outside (e.g. Section 4.7, Diekmann
t al., 2013). However, it is still possible to distinguish between
ubcritical epidemics in which the epidemic will die out quickly
nd supercritical epidemics in which it takes an exponential (in
he stationary population size) time to go extinct.
If the population is growing, e.g. if the population grows accord-
ng to a birth and death process, then it is possible that the epidemic
urvives forever. Ignoring population structure, such model has
een studied in Britton and Trapman (2014). It is shown that there
re different regimes of survival. It might be that the epidemic
urvives, but the number of infectious individuals increases at
lower speed than the population does, so the fraction of infecteds 10 (2015) 54–57
individuals goes to 0. It is also possible that the population and epi-
demic reach equilibrium and the fraction of infectious individuals
converges to a constant. Some theoretical mathematical questions
are still open (cf. Britton and Trapman, 2014.), in addition to rel-
evant challenges from an epidemiological perspective. Examples
of challenging questions are: Can an epidemic spread so fast, that,
because of the quick depletion of susceptible individuals, after the
ﬁrst wave of the epidemic the epidemic still dies out with relatively
large probability? If yes, what is the probability of this relatively fast
extinction, and how does it depend on the model parameters?
The real challenge however lies in taking network structure into
account in growing populations. We  consider the most basic model,
in which the population is governed by a linear birth and death
model. Newly born individuals do not have connections yet and
every individual acquires new connections at a ﬁxed rate and con-
nections are broken at another rate (cf. Britton et al., 2011). On  this
network a Markov SIR epidemic model can be considered. In addi-
tion to the open questions which already appear in the unstructured
populations, questions arise due to dependencies which naturally
appear in those networks (Britton et al., 2011). Even writing down
an expression for R0 in this model is not trivial (see Leung et al., 2012
for a similar model). One possible way to attack this open question
is to work via inﬁnite type branching processes, where the type of
an infectious individual is its age at the moment of its infection.
Adaptions of methods from Ball et al. (2013) might be used to give
(implicit) expressions for R0 and the probability of extinction of a
SIR epidemic introduced by a single individual in an already large
population.
5. Mutation and evolution
How can we represent the process of pathogen mutation (an
inherently stochastic process) and associated ﬁtness change within
global epidemic models so as to capture observed evolutionary
patterns with sufﬁcient accuracy for the question at hand?
Patterns of incidence for all host-pathogen systems are inﬂu-
enced by evolution. However, the scale at which these changes
can be observed in both time and space varies massively from
one system to another. For many important human viruses, such
as smallpox (prior to its eradication) and measles, rates are so
slow they can safely be ignored. However, for antigenically vari-
able viruses such as inﬂuenza and dengue and for most bacteria
models that do not represent evolutionary processes in some way
fail to capture even coarse patterns of incidence beyond relatively
short periods of time or distances. The results of evolution can be
seen directly when genotypic or phenotypic data are available, such
as in the antigenic relationship between circulating strains of viral
infections or in the proportion of bacterial isolates resistant to a
speciﬁc treatment. Also, these phenotypic traits often drive crude
measures of incidence even when they are not observed. The joint
representation of evolutionary phylogenies and epidemic dynam-
ics within the same quantitative framework is often referred to as
phylodynamics (Grenfell et al., 2004).
Inﬂuenza in humans is the canonical example of an antigenically
variable pathogen evolving rapidly in space and time: globally rec-
ommended vaccines need to be updated every few years (Smith
et al., 2004) and resistance to established treatments emerges reg-
ularly (Graitcer et al., 2011) and spreads rapidly. However, despite
early progress (Ferguson et al., 2003; Koelle et al., 2006), the rep-
resentation of evolution at the global scale in a way that can be
robustly tested with available data remains challenging (Ratmann
et al., 2012). Simulation approaches that represent a subset of a
consensus viral genome sequence for each infected individual will
undoubtedly be extended to larger host populations with more
accurate transport models, until they eventually reach a genuinely
global scale.
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The challenges presented by bacteria to large epidemic mod-
ls are different from those of viruses (Gray et al., 2011). Bacterial
opulations evolve much more slowly and, in general, maintain
eographically distinct lineages for much longer periods than do
apidly mutating viruses. Also, relative to point mutations, the
ecombination of bacteria (in which large portions of genes are
xchanged during co-infection of different lineages) is much more
mportant than is the reassortment of segmented viruses such
s inﬂuenza (in which whole genes are exchanged). Therefore,
o date, there has not been sufﬁcient motivation to attempt the
onstruction of global-scale models of key bacterial species such
s Staphylococcus aureus.  However, the increasing clinical impor-
ance of strains resistant to more than one treatment (Levy and
arshall, 2004) may  well motivate exactly these types of analy-
es. In particular, the degree to which excessive use of antibiotics
n one population inﬂuences the incidence of resistant strains in
eighbouring populations is a question that naturally leads to
lobal-scale analyses.
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